RxDoctor Payments Data

Maria Heck

Family · Huntington, WVNPI 1255958922

Payments from drug & device makers

$703in general payments, 2019–2025

Across 38 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$153
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$113
  • Phathom Pharmaceuticals, Inc.$71
  • Novo Nordisk$66
  • Madrigal Pharmaceuticals$49
  • Lilly USA, LLC$47
  • plus $205 from 8 others

What the payments were for

  • Food & beverage$703100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$703 in reported general payments places this provider in the 60th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$9,634
Medicare patients
115
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XifaxanRifaximin14$38,520
LinzessLinaclotide17$15,494
Dexlansoprazole DrDexlansoprazole34$8,914
Sucralfate32$4,758
Pantoprazole Sodium163$2,423
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl39$708
Omeprazole38$522
Famotidine22$394
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl14$277
Amitriptyline Hcl13$121

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$113$38,52014 claims
AbbVieLinzess$153$15,49417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,507 family providers in West Virginia.

Other family in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →